ASH Earnings Date: Nov 3, 2026 — Ashland Inc.
NYSE · Materials · Specialty Chemicals
Updated
When is ASH's next earnings date?
Ashland Inc. (ASH) is scheduled to report Q4 2026 earnings on Tuesday, November 3, 2026 at 5:01 PM ET (after market close). The consensus estimate is EPS of $1.27 on revenue of $501.8M.
How did ASH do in its last earnings report?
In its most recent report on Jul 28, 2026 (Q3 2026), Ashland Inc. posted EPS of $1.02 versus the $1.04 estimate, a miss of 1.9%. Revenue was $497.0M against a $485.8M estimate. The stock's 1-day post-earnings move was +7.1%.
How much does ASH stock move after earnings?
ASH beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.6% (up or down) in the day after earnings.
About Ashland Inc.
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-28 | Q3 2026 | 1.04 | 1.02 | -1.92% | $497.0M | ❌ Miss | +7.10% | +6.34% | +9.27% |
| 2026-04-28 | Q2 2026 | 0.95 | 0.91 | -4.21% | $482.0M | ❌ Miss | -13.78% | -8.32% | +0.57% |
| 2026-02-02 | Q1 2026 | 0.24 | 0.26 | +8.33% | $386.0M | ✅ Beat | -0.78% | +1.11% | -1.84% |
| 2025-11-04 | Q4 2025 | 1.23 | 1.08 | -12.20% | $478.0M | ❌ Miss | +6.06% | +4.64% | +22.80% |
| 2025-07-29 | Q3 2025 | 1.18 | 1.04 | -11.86% | $463.0M | ❌ Miss | +5.57% | +3.82% | +12.63% |
| 2025-04-30 | Q2 2025 | 1.10 | 0.99 | -10.00% | $479.0M | ❌ Miss | -9.85% | -11.06% | -8.22% |
| 2025-01-28 | Q1 2025 | 0.18 | 0.28 | +55.56% | $405.0M | ✅ Beat | -9.82% | -9.45% | -13.57% |
| 2024-11-06 | Q4 2024 | 1.28 | 1.26 | -1.56% | $522.0M | ❌ Miss | -7.64% | -11.37% | -13.15% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $338.0M total
| Segment | Share | Revenue | YoY | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 |
|---|---|---|---|---|---|---|---|
| Specialty Additives | 32.5% | $110.0M | — | $122.0M | $157.0M | $150.0M | $293.0M |
| Life Sciences | 31.4% | $106.0M | — | $200.0M | $222.0M | $195.0M | $388.0M |
| Personal Care And Household | 26.6% | $90.0M | — | $129.0M | $169.0M | $175.0M | $336.0M |
| Intermediates And Solvents | 9.5% | $32.0M | — | $33.0M | $40.0M | $36.0M | $71.0M |
By region
FY2024 · $2.11B total · annual
| Segment | Share | Revenue | YoY | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|
| Non-US | 70.5% | $1.49B | -4.4% | — | — | — | — |
| UNITED STATES | 29.5% | $624.0M | -1.6% | $1.42B | $959.0M | $878.0M | $637.0M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.